Literature DB >> 15515413

Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron.

W Müller1, T Stratz.   

Abstract

UNLABELLED: The use of local tropisetron injections improved the treatment of tendinopathies considerably, with the effect being comparable to the topical application of local anaesthetics combined with depot corticosteroids. On the other hand, local injection of prilocaine alone exerted a shorter and weaker effect on the condition.
OBJECTIVES: After it had been proven that systemic application of the 5-HT3 receptor antagonist tropisetron exerts an analgesic effect on musculoskeletal pain in fibromyalgia, we investigated the efficacy of the substance in tendinopathies and myofascial pain syndromes.
RESULTS: Local injections of tropisetron as a treatment for trigger points in myofascial pain syndrome also brought about rapid and prolonged relief in the majority of cases. The analgesic effect was far superior to the action of local anaesthetics.
CONCLUSION: The present findings indicate that the analgesic action of the 5-HT3 receptor antagonist tropisetron sets in rapidly and lasts for a long time. Various mechanisms are under discussion to explain the long duration of the effect. Tropisetron not only has an analgesic but probably also an antiphlogistic effect which can be attributed to the inhibited release of substance P and other neuropeptides from the nociceptors and the blocked release of phlogistic substances from macrophages, monocytes etc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15515413

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  8 in total

Review 1.  Clinical implication of latent myofascial trigger point.

Authors:  Derya Celik; Ebru Kaya Mutlu
Journal:  Curr Pain Headache Rep       Date:  2013-08

2.  Dry needling - peripheral and central considerations.

Authors:  Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2011-11

Review 3.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

4.  Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron.

Authors:  Farinaz Nasirinezhad; Marjan Hosseini; Zohre Karami; Mahmoud Yousefifard; Autosa Janzadeh
Journal:  J Spinal Cord Med       Date:  2015-09-04       Impact factor: 1.985

Review 5.  Immunomodulatory effects mediated by serotonin.

Authors:  Rodrigo Arreola; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Marco Antonio Velasco-Velázquez; María Eugenia Garcés-Alvarez; Gabriela Hurtado-Alvarado; Saray Quintero-Fabian; Lenin Pavón
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

6.  Myofascial pain syndrome: a treatment review.

Authors:  Mehul J Desai; Vikramjeet Saini; Shawnjeet Saini
Journal:  Pain Ther       Date:  2013-02-12

7.  Expression of 5-HT3 receptors and TTX resistant sodium channels (Na(V)1.8) on muscle nerve fibers in pain-free humans and patients with chronic myofascial temporomandibular disorders.

Authors:  Nikolaos Christidis; Isabell Kang; Brian E Cairns; Ujendra Kumar; Xudong Dong; Annika Rosén; Sigvard Kopp; Malin Ernberg
Journal:  J Headache Pain       Date:  2014-09-26       Impact factor: 7.277

8.  Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.

Authors:  Nikolaos Christidis; Shahin Omrani; Lars Fredriksson; Mattias Gjelset; Sofia Louca; Britt Hedenberg-Magnusson; Malin Ernberg
Journal:  J Headache Pain       Date:  2015-12-03       Impact factor: 7.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.